Keywords: genzyme, 2nd-qtr, net, income, jumps, biotechnology, major
Genzyme's 2nd-qtr net income jumps 4%
Article | 06 August 2007
US biotechnology major Genzyme's second-quarter 2007 profit totaled $139.9 million, or $0.51 per share, up 4% on the like, year-ago period, as revenues jumped 18% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
